A clinical trial to study the efficacy and safety of zinc in prevention of oral mucositis in children receiving chemotherapy
Phase 2
- Conditions
- Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]Health Condition 2: C920- Acute myeloblastic leukemiaHealth Condition 3: C801- Malignant (primary) neoplasm, unspecifiedHealth Condition 4: C409- Malignant neoplasm of unspecifiedbones and articular cartilage of limbHealth Condition 5: C851- Unspecified B-cell lymphoma
- Registration Number
- CTRI/2021/02/031600
- Lead Sponsor
- All India Institute Of Medical Sciences New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients of 3-18 years of age with cancer receiving intensified chemotherapy
2.Informed consent
3.No any oral lesion at the time of enrollment
Exclusion Criteria
1.Patient receiving intensified chemotherapy over a period of more than five days
2.If child received systematic zinc within last 14 days for any indication for a period of more than 5 days.
3.Any contra-indications to the use of oral zinc:
3.1 Any documented allergic reaction/hypersensitivity to oral zinc
3.2 Any patient who is vomiting excessively due to any cause.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method